Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Voyager Therapeutics, Inc. | vygr-20171231ex321ad5904.htm |
| EX-31.2 - EX-31.2 - Voyager Therapeutics, Inc. | vygr-20171231ex3123b26df.htm |
| EX-31.1 - EX-31.1 - Voyager Therapeutics, Inc. | vygr-20171231ex311f85e86.htm |
| EX-21.1 - EX-21.1 - Voyager Therapeutics, Inc. | vygr-20171231ex211199c06.htm |
| EX-10.22 - EX-10.22 - Voyager Therapeutics, Inc. | vygr-20171231ex10229c9cb.htm |
| EX-10.21 - EX-10.21 - Voyager Therapeutics, Inc. | vygr-20171231ex1021617d8.htm |
| EX-4.1 - EX-4.1 - Voyager Therapeutics, Inc. | vygr-20171231ex4167a89f3.htm |
| 10-K - 10-K - Voyager Therapeutics, Inc. | vygr-20171231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
· |
Registration Statement (Form S-3 No. 333-214861) of Voyager Therapeutics, Inc. |
|
· |
Registration Statement (Form S-8 No. 333-207958) pertaining to the 2014 Stock Option and Grant Plan, the 2015 Stock Option and Incentive Plan, and the 2015 Employee Stock Purchase Plan of Voyager Therapeutics, Inc. |
|
· |
Registration Statement (Form S-8 No. 333-210258) pertaining to the 2015 Stock Option and Incentive Plan and the 2015 Employee Stock Purchase Plan of Voyager Therapeutics, Inc. |
|
· |
Registration Statement (Form S-8 No. 333-216699) pertaining to the 2015 Stock Option and Incentive Plan and the 2015 Employee Stock Purchase Plan of Voyager Therapeutics, Inc. |
of our report dated March 14, 2018 with respect to the consolidated financial statements of Voyager Therapeutics, Inc. included in this Annual Report (Form 10-K) of Voyager Therapeutics, Inc. for the year ended December 31, 2017.
/s/ Ernst & Young, LLP
Boston, Massachusetts
March 14, 2018